ArticleJournal of medicinal chemistry2012

De novo peptide design with C3a receptor agonist and antagonist activities: theoretical predictions and experimental validation.

Meghan L Bellows-Peterson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.